DMS in Rapid Identification of Brain Tumours
Ilkka Haapala’s PhD dissertation explored the possibility of differentiating tumour types and specific mutations based on DMS. We want to congratulate Ilkka on his successful defense of the dissertation!
Read the latest news on VOC detection
Ilkka Haapala’s PhD dissertation explored the possibility of differentiating tumour types and specific mutations based on DMS. We want to congratulate Ilkka on his successful defense of the dissertation!
Our CTO Osmo Anttalainen has successfully defended his PhD dissertation at University of Helsinki. Congratulations Osmo!
Our COO, Anton Kontunen, participated in the exciting exhibition at The Smarter E Europe event in Munich, Germany, on the 19th and 20th of June.
Our CTO Osmo Anttalainen visited KOTRA in Stockholm, Sweden. The conference dove into the latest advancements in battery technology.
Lithium ion battery recycling is a rapidly growing industry, since exponentially more batteries are coming to their end of life. Safe recycling requires proper handling of the batteries.
The IonVision DMS sensor was delivered to a customer for evaluation in industrial scale battery leak detection.
Read the latest articles regarding IonVision DMS published from our development team
Patient-derived glioma organoids were utilized in testing DMS’s viability in IDH mutation detection. The open access article has now been published!
DMS-based tissue identification works not only with monopolar electrosurgery, but with ultrasonic instruments as well. The open-access article has been published in Microchemical Journal!
An article on the identification of phospholipids relevant to cancer tissue using DMS has been published in the International Journal of Molecular Sciences! Identification of three cancer-relevant phospholipids (PC, PI, and PE) was studied.
An article on the rapid identification of pediatric brain tumors using DMS was published in Frontiers in Oncology, section Neuro-Oncology and Neurosurgical Oncology!
An original research article on bioprocess monitoring with the IonVision DMS is now available as open access!
Olfactomics IonVision was used to assess the prognostically significant IDH mutation status in various central nervous system malignanies. The Open access article is now out!
Here you can find our latest blog posts, white papers and application notes regarding our DMS technology
This blog post is an adaptation from an R notebook that is shared in our GitHub. We show some sections of the IonVision data structure, and plot and explain some DMS spectra.
Changes in humidity influence the sensitivity of DMS. Here we describe how PDMS membranes can be used to dry samples.
The second part of our blog about pilot testing is now up! We describe how we conduct pilot studies and how this all ties into the SynbioPro project.
The first part of our blog about pilot testing is now up! We describe the necessary steps to get from an idea to a full pilot-study.
Want to hear more about us?
Are You the missing link in our growing team of professionals?
Don’t hesitate to contact us!
Please fill out the form and we will be in touch.
email: info@olfactomics.fi
tel: +358 408410698
Address:
Korkeakoulunkatu 7
Kampusareena
FI-33720 Tampere, FINLAND
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreements No 827034 and No 848682.